2018-03-15

       2018年3月15日上午，諾康達總經(jīng)理陶秀梅女士，副總經(jīng)理尚麗霞女士，制劑總監(jiān)王卓先生會見了蒙古國最大的醫(yī)藥集團Monos Pharma LLC的Enkhzaya Bayaraa女士、Tula女士、國藥集團王增繪先生洽談多個仿制藥品種研發(fā)及工藝技術輸出合作。
       On the morning of March 15^th 2018, Ms. Tao Xiumei, the General Manager of Nuokangda, Ms. Shang Lixia, the Vice General Manager, and Mr. Wang Zhuo, the Formulation Director, met with Ms. Enkhzaya Bayaraa, the factory director of Monos Pharma LLC, which is the largest  pharmaceutical company in Mongolia. Both parties have already reached cooperation intention of a series of generic drug R&D technology output.

          總經(jīng)理陶秀梅對Zaya女士一行到訪諾康達表示熱烈歡迎，向客人詳細介紹了諾康達的發(fā)展歷程、業(yè)務模式、人員團隊、高質量的硬件設施保障體系和國際合作優(yōu)勢等。Zaya女士介紹了蒙古醫(yī)療和醫(yī)藥衛(wèi)生現(xiàn)狀，藥品開發(fā)的一般流程，及Monos藥廠生產(chǎn)線特點。陶總帶領參觀了諾康達的實驗室以及移動式整粒機、搖擺制粒機、濕法制粒機、氣流粉碎機、濕法混合制粒機、高效包衣機、高剪切乳化分散機、膠囊灌裝機等儀器設備，Zaya女士對于諾康達的先進的硬件設施和高效的研發(fā)團隊表示由衷的贊許和驚嘆，期待雙方合作后，諾康達能作為輸出品種的技術培訓基地，同時為‘一帶一路’沿線國家培養(yǎng)醫(yī)藥研發(fā)的高技能人才。諾康達期待與Monos未來能將有著悠久歷史的蒙藥方劑進行現(xiàn)代化的開發(fā)，開發(fā)出符合蒙古人民用藥習慣的、療效好的藥品。并且逐步將特殊醫(yī)用營養(yǎng)以及醫(yī)療器械等多種儲備項目全面向蒙古國進行技術推廣和轉移。
       Ms.Tao Xiumei, warmly welcomed Ms. Zaya and her delegations to Nuokangda. Nuokangda’s fast development history, the business model, the team, the high-quality hardware facilities as well as the international cooperation advantages were introduced to the guests. Subsequently, Ms. Zaya introduced the medical and health conditions of Mongolia, the drug R&D process, and the production line of Monos Pharma. Then, Ms. Tao led the guests to the lab visiting the HPLC, swing granulator, the wet mixing granulator, the efficient coating machine, and high-shear emulsifying disperser, etc. Ms.Zaya showed her heartfelt praise and surprise to Nuokangda's highly advanced hardware facilities, and hope that Nuokangda can serve as a tech exporting training base for Monos Pharma after cooperation, and can train more talents in the pharmaceutical science field for countries along the “Belt and Road”. Nuokangda expects to modernize the traditional Mongolian medicine prescriptions with Monos Pharma in the future, and the developed drug will meet the habits and requirement of Mongolian people. In the future, besides the generic drug, special medical use nutrition and medical devices will gradually transfer to Mongolia.



       
          風起揚帆正當時，四海同心逐新夢。作為人類建設命運共同體和平發(fā)展的創(chuàng)新之舉，“一帶一路”建設成效顯著。諾康達深入學習“一帶一路”的國家戰(zhàn)略思想，高度踐行“一帶一路”的國家戰(zhàn)略。正是得益于國家的繁榮富強，高速成長的諾康達才能有幸參與到“一帶一路”的具體項目的實施過程。諾康達此次與蒙古國開展的合作項目，作為醫(yī)藥研發(fā)領域的“一帶一路”領域的先行先試，必將會引領越來越多的醫(yī)藥研發(fā)以及生產(chǎn)企業(yè)更多地參與到國家“一帶一路”的偉大事業(yè)！共同鑄就團結，發(fā)展，文明，繁榮的希望之夢！
      When the winds sailed, the world is moving toward a goal. As an innovative move in the development of human destiny and peaceful, “the Belt and Road” has achieved remarkable achievement. Nuokangda has thoroughly studied and then highly practiced the national strategy of “the Belt and Road ”. Thanks to the prosperity and prosperity of the country, Nuokandga has the privilege of participating in the business cooperation with Mongolia this time. The cooperation between Nuokangda and Monos Pharma, as a pioneer to implement“the Belt and Road ”strategy in the pharmaceutical science field, is very meaningful and will surely lead more and more pharmaceutical companies to participate in for the great cause of the country. Let us strive to create a unity, development, civilization, and prosperity society!